翰宇药业：2025年半年度营业收入同比增长114.86%

Core Insights - Han Yu Pharmaceutical reported a significant increase in revenue and net profit for the first half of 2025, indicating strong financial performance [2] Financial Performance - The company achieved operating revenue of 549,442,106.79 yuan, representing a year-on-year growth of 114.86% [2] - The net profit attributable to shareholders of the listed company was 145,468,616.41 yuan [2]